Issue Date: April 15, 2013
GlaxoSmithKline Goes Beyond Pharmaceuticals
GlaxoSmithKline wants to explore whether diseases can be treated and health restored by modulating neural impulses in the body. Last week the British drug company announced it will support a nascent field it calls “electroceuticals” with funds for 20 external labs and a $1 million prize.
“We see this as a new treatment modality—something in parallel with small molecules, protein therapeutics, and vaccines—by which we hope we can treat diseases,” says Kristoffer Famm, . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society